about
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery te...
Read More
1.57
-0.09
(-5.42%)
9,289
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Pulmatrix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..